tailieunhanh - Emergency Contraception: Clinical Effectiveness Unit

Qualitative research was conducted on these issues in the 1990s, but since then, India has experienced rapid economic growth, considerable improvements in net school enrolment ratios, and reductions in gender differentials in school enrolment. In this changing scenario, how do young women with different amounts of schooling experience the transitions from adolescence into adulthood? In particular, what difference does schooling make to the experiences of poor young women, in urban and rural areas in north India? The key transitions that young women face in north India are, in the terms set out by the recent World Development Report (World Bank. | -------FACULTY-------- -----OF SEXUAL------ REPRODUCTIVE HEALTHCARE Faculty of Sexual Reproductive Healthcare Clinical Guidance Emergency Contraception Clinical Effectiveness Unit August 2011 Updated January 2012 ISSN 1755-103X DETAILS OF CHANGES TO ORIGINAL GUIDANCE DOCUMENT The original version of this CEU Guidance Document issued in August 2011 contained some inconsistencies that the CEU has corrected in this version. These amendments are as follows additional recommendation regarding offering a Cu-IUD to eligible women presenting between 0 and 120 hours of UPSI or within 5 days of expected ovulation added pages ii and 8 references 12 and 13 updated page 11 and acknowledgement of chart designer added to Appendix 2 page 15 . ABBREVIATIONS USED BMI body mass index CEU Clinical Effectiveness Unit CHC combined hormonal contraception Cu-IUD copper-bearing intrauterine device DMPA depot medroxyprogesterone acetate EC emergency contraception FSRH Faculty of Sexual and Reproductive Healthcare LNG levonorgestrel LNG-IUS levonorgestrel-releasing intrauterine system NET-EN norethisterone enantate PEPSE post-exposure HIV prophylaxis after sexual exposure POP progestogen-only pill SPC Summary of Product Characteristics STI sexually transmitted infection UKMEC UK Medical Eligibility Criteria for Contraceptive Use UPA ulipristal acetate UPSI unprotected sexual intercourse WHOMEC World Health Organization Medical Eligibility Criteria for Contraceptive Use GRADING OF RECOMMENDATIONS Evidence based on randomised controlled trials Evidence based on other robust experimental or observational studies Evidence is limited but the advice relies on expert opinion and has the endorsement of respected authorities Good Practice Point where no evidence exists but where best practice is based on the clinical experience of the multidisciplinary group Published by the Faculty of Sexual and Reproductive Healthcare Registered in England No. 2804213 and Registered Charity No. 1019969 First .

crossorigin="anonymous">
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.